1.A Case of Perianal Adenocarcinoma Developing in Chronic Tuberculous Anal Fistula.
Joon Ho KIM ; Seok Hwan LEE ; Young Gwan KO ; Choong YOON ; Sung Jig LIM ; Moon Ho YANG ; Jung Joon YOO ; Kee Hyung LEE
Journal of the Korean Society of Coloproctology 1998;14(3):611-616
Mucinous adenocarcinomas of the anal region constitute only 2% of anal cancer and adenocarcinoma developing in a chronic tuberculous anal fistula is extremely rare. In most cases, its origin is difficult to ascertain because the primary sites have already been destroyed before any diagnosis of malignancy is made. We experienced a case of perianal adcnocarcinoma developing in chronic tuberculous anal fistula, which was treated by abdominoperineal resection with preoperative chemo-irradiation. We reported a case and reviewed the related literatures.
Adenocarcinoma*
;
Adenocarcinoma, Mucinous
;
Anus Neoplasms
;
Diagnosis
;
Rectal Fistula*
2.Insufficiency fracture after radiation therapy.
Radiation Oncology Journal 2014;32(4):213-220
Insufficiency fracture occurs when normal or physiological stress applied to weakened bone with demineralization and decreased elastic resistance. Recently, many studies reported the development of IF after radiation therapy (RT) in gynecological cancer, prostate cancer, anal cancer and rectal cancer. The RT-induced insufficiency fracture is a common complication during the follow-up using modern imaging studies. The clinical suspicion and knowledge the characteristic imaging patterns of insufficiency fracture is essential to differentiate it from metastatic bone lesions, because it sometimes cause severe pain, and it may be confused with bone metastasis.
Anus Neoplasms
;
Follow-Up Studies
;
Fractures, Stress*
;
Neoplasm Metastasis
;
Prostatic Neoplasms
;
Rectal Neoplasms
;
Stress, Physiological
3.The 3-Dimensional Analysis of the Efficacy of a Belly-Board Device for the Displacement of Small Bowel During Pelvic Irradiation.
The Journal of the Korean Society for Therapeutic Radiology and Oncology 2008;26(4):271-279
PURPOSE: To evaluate the efficacy of a belly-board device (BBD) in reducing the volume of small bowel during four-field pelvic irradiation. MATERIALS AND METHODS: Twenty-two cancer patients (14 uterine cervical cancer, 6 rectal cancer, and 2 endometrial cancer) scheduled to receive pelvic irradiation were selected for this study. Two sets of CT images were taken with and without the belly-board device using the Siemens 16 channel CT scanner. All patients were set in the prone position. The CT images were transferred to a treatment planning system for dose calculation and volume measurements. The external surfaces of small bowel and the bladder were contoured on all CT scans and the 4-pelvic fields were added. The dose-volume-histogram of the bladder and small bowel, with and without the BBD, were plotted and analyzed. RESULTS: In all patients, the total small bowel volume included in the irradiated fields was reduced when the BBD was used. The mean volume reduction was 35% (range, 1~79%) and was statistically significant (p<0.001). The reduction in small bowel volume receiving 10~100% of the prescribed dose was statistically significant when the BBD was used in all cases. Almost no change in the total bladder volume involved was observed in the field (<8 cc, p=0.762). However, the bladder volume receiving 90% of the prescribed dose was 100% in 15/22 patients (68%) and 90~99% in 7/22 patients (32%) with the BBD. In comparison, the bladder volume receiving 90% of the prescribed dose was 100% in 10/22 patients (45%), 90~99% in 7/22 patients (32%), and 80~89% in 5/22 patients (23%) without the BBD. When the BBD was used, an increase in the bladder volume receiving a high dose range was observed. CONCLUSION: This study shows that the use of a BBD for the treatment of cancer in the pelvic area significantly improves small bowel sparing. However, since the BBD pushed the bladder into the treatment field, the bladder volume receiving the high dose could increase. Therefore it is recommended to be considerate in using the BBD when bladder damage is of concern.
Rectal Neoplasms
4.Factors Influencing Oncologic Outcomes after Tumor-specific Mesorectal Excision for Rectal Cancer.
Journal of the Korean Society of Coloproctology 2012;28(2):71-72
No abstract available.
Rectal Neoplasms
5.Sexual Function After a Proctectomy for the Treatment of Rectal Cancer.
Annals of Coloproctology 2014;30(5):205-205
No abstract available.
Rectal Neoplasms*
6.Clinical observation on resectable cases after preoperative radiation therapy in initially unresectable rectal cancer.
Ho Se HAN ; Yong Shin KIM ; Kwang Yun KIM
Journal of the Korean Surgical Society 1992;43(4):560-566
No abstract available.
Rectal Neoplasms*
7.A clinical analysis of rectal cancer.
Journal of the Korean Society of Coloproctology 1993;9(3):243-250
No abstract available.
Rectal Neoplasms*
8.Outcome of low anterior resection by EEA stapler and standard manual anastomosis in rectal cancer.
Jae Hong KWON ; Nam Cheon CHO ; Kwang Soo YOON ; Dae Sung KIM ; Soo Yong KIM
Journal of the Korean Surgical Society 1991;41(3):352-357
No abstract available.
Rectal Neoplasms*
9.Small bowel obstruction after abdominoperineal resection for rectal cancer.
Kyu Hak SHIM ; Chul MOON ; Hee YOO
Journal of the Korean Society of Coloproctology 1992;8(2):129-135
No abstract available.
Rectal Neoplasms*
10.Clinical review of low anterior resection for rectal cancer using double stapling technique.
Byung Seok KIM ; Duk Jin MOON ; Ju Sup PARK
Journal of the Korean Society of Coloproctology 1993;9(2):143-150
No abstract available.
Rectal Neoplasms*